Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
NCT06666634Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Apr 2023
- Primary completion
- Jul 2025
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green + technetium Tc 99m nanocolloid in penile cancer, melanoma and oral cancer, sponsored by Netherlands Cancer Institute. Primary endpoint: Concordance between tracers. Started Apr 2023; status: completed.
02
Drugs
indocyanine green + technetium Tc 99m nanocolloid
03
Conditions
penile cancermelanomaoral cancer
Beyond the preview
Go deeper on NCT06666634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06666634.